36 completed, 6 unknown, 4 terminated, 3 not yet recruiting. 14 Phase 3, 11 Phase 2, 10 Not applicable, 10 Phase 1, 1 Phase 4.
Follow Central Nervous System Parasitic Infections: new trials by email Literature Review of Central Nervous System Parasitic Infections trials Research Report on Central Nervous System Parasitic Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Oxfendazole in Mild Parenchymal Brain Cysticercosis Oxfendazole single dose, Oxfendazole three doses, albendazole plus praziquantel regime - Brain Cysticercosis | Phase 2 / Phase 3 | Not yet recruiting | Universidad Peruana Cayetano Heredia | 544 | 2026-12-01 | 2026-05-01 |
| The Impact of Medical TV Drama in Improving Literacy on Neurocysticercosis Medical TV Drama Episode (House M.D.) - Neurocysticercosis, Health Literacy | Not applicable | Not yet recruiting | Cephas Health Research Initiative Inc, Ibadan, Nigeria | 60 | 2025-12-15 | 2025-12-04 |
| Study of a Cohort of Non-HIV Immunocompromised Patients With Toxoplasmosis at the Strasbourg University Hospital Cerebral Toxoplasmosis | Recruiting | University Hospital, Strasbourg, France | 30 | 2025-02-02 | 2025-12-23 | |
| Analysis of Cerebrospinal Fluid in Patients With Cerebral Toxoplasmosis at CHSD (2004-2024) Toxoplasmosis, Cerebral, Toxoplasmosis | Completed | Centre Hospitalier de Saint-Denis | 53 | 2024-07-01 | 2025-06-29 | |
| Assessment of Combined Praziquantel and Albendazole vs Albendazole Alone to Treat Active Parenchymal Neurocysticercosis albendazole and praziquantel, Albendazole - Neurocysticercosis | Phase 4 | Not yet recruiting | R-Evolution Worldwide S.r.l. Impresa Sociale | 300 | 2024-06-01 | 2024-04-23 |
| Pregnancy and Congenital Toxoplasmosis Estimation of the occurrence of retinochoroiditis in women with congenital toxoplasmosis and previous retinochoroiditis lesions (recurrence) during pregnancy and postpartum. - Congenital Toxoplasmosis, Retinochoroiditis | Completed | Hospices Civils de Lyon | 76 | 2023-05-10 | 2026-01-22 | |
| DON in Pediatric Cerebral Malaria 6-diazo-5-oxo-L-norleucine (DON), Placebo - Malaria, Cerebral | Phase 1 / Phase 2 | Recruiting | Douglas Postels, MD, MS | 152 | 2022-08-16 | 2026-10-23 |
| Automated Detection of Malarial Retinopathy in Patients Diagnosed With Cerebral Malaria Automated software for malarial retinopathy detection - Cerebral Malaria, Malarial Retinopathy | Completed | VisionQuest Biomedical LLC | 834 | 2022-03-15 | 2025-07-03 | |
| Diagnosis of Toxoplasma Gondii Infection by Exploration of Cellular Immunity (TOXCELL) anti-Toxoplasma gondii IgG and IgM dosage, cellular test - Toxoplasmosis, Toxoplasma Infections | Not applicable | Completed | Centre Hospitalier Universitaire de Nice | 66 | 2021-11-17 | 2024-10-15 |
| Dexamethasone for Cerebral Toxoplasmosis Dexamethasone, Placebo - Toxoplasmosis, Cerebral | Phase 2 | Unknown | Universitas Padjadjaran | 138 | 2021-04-16 | 2024-07-03 |
| Parenchymal and Extraparenchymal Neurocysticercosis-A Registry Based Study Neurocysticercosis, Tropical Disease | Unknown | All India Institute of Medical Sciences | 1000 | 2021-01-15 | 2021-01-13 | |
| Investigation of Environmental Factors Associated With Transmission of T. Solium in Endemic Villages of Zambia Neurocysticercosis, Taeniosis | Completed | Technical University of Munich | 2921 | 2019-06-01 | 2023-11-30 | |
| Treatment of Patients With Active Neurocysticercosis in Eastern Africa Neurocysticercosis | Completed | Technical University of Munich | 63 | 2019-04-01 | 2023-11-30 | |
| New Diagnostic Approach for Congenital Toxoplasmosis blood additional samples - Congenital Toxoplasmosis | Not applicable | Completed | Assistance Publique - Hôpitaux de Paris | 70 | 2018-06-20 | 2026-08-11 |
| The Burden of (Neuro)Cysticercosis Among People Living With HIV in Rural Tanzania Diagnosis of (Neuro)cysticercosis - Neurocysticercosis, HIV/AIDS | Completed | Technical University of Munich | 2584 | 2018-04-01 | 2023-11-29 | |
| Treating Brain Swelling in Pediatric Cerebral Malaria Mechanical ventilation, Hypertonic saline - Malaria, Cerebral | Phase 3 | Completed | Michigan State University | 57 | 2018-01-08 | 2025-03-17 |
| Sub Arachnoid Neurocysticercosis Treatment Outcome (SANTO) Albendazole and praziquantel, Albendazole and praziquantel placebo - Neurocysticercosis | Phase 3 | Terminated | Universidad Peruana Cayetano Heredia | 107 | 2016-11-14 | 2022-11-16 |
| Single Ascending Dose Safety Study of Oxfendazole oxfendazole, placebo - Tenia Solium Infection | Phase 1 | Withdrawn | Johns Hopkins Bloomberg School of Public Health | 2016-08-01 | 2016-08-30 | |
| Driving Reduced AIDS-associated Meningo-encephalitis Mortality DREAMM - AIDS-Related Opportunistic Infections, Meningo-encephalitis | Not applicable | Completed | St George's, University of London | 495 | 2016-04-23 | 2022-05-04 |
| Treatment of Peri-calcification Edema in Neurocysticercosis (NCC) Acetazolamide, Dexamethasone - Neurocysticercosis | Phase 2 / Phase 3 | Terminated | Universidad Peruana Cayetano Heredia | 4 | 2015-12-04 | 2025-04-01 |
Showing 20 of 53. Sign in to see all of them.
Neurocysticercosis (20) · Malaria, Cerebral (14) · Toxoplasmosis, Cerebral (13) · Toxoplasmosis (10) · Acquired Immunodeficiency Syndrome (9) · HIV Infections (9) · Taeniasis (9) · Encephalitis (7) · Epilepsy (7) · Malaria (7) · Toxoplasmosis, Congenital (6) · AIDS-Related Opportunistic Infections (5) · Seizures (5) · Cestode Infections (3) · Cysticercosis (3)
Central Nervous System Diseases (53) · Infections (53) · Parasitic Diseases (53) · Central Nervous System Infections (52) · Nervous System Diseases (52) · Central Nervous System Protozoal Infections (33) · Protozoan Infections (33) · Brain Diseases (21) · Central Nervous System Helminthiasis (20) · Helminthiasis (20) · Coccidiosis (19) · Cestode Infections (17) · Cysticercosis (17) · Mosquito-Borne Diseases (14)
Pyrimethamine (8) · Albendazole (7) · Leucovorin (5) · Dexamethasone (3) · Praziquantel (3) · oxfendazole (3) · Atovaquone (2) · Clindamycin (2) · Levetiracetam (2) · Mannitol (2) · Sulfadiazine (2) · Acetazolamide (1) · Air (1) · Azithromycin (1) · Clarithromycin (1)
National Institute of Allergy and Infectious Diseases (NIAID) (9) · Universidad Peruana Cayetano Heredia (4) · Makerere University (3) · Technical University of Munich (3) · All India Institute of Medical Sciences (2) · Assistance Publique - Hôpitaux de Paris (2) · Hospices Civils de Lyon (2) · National Institute of Mental Health (NIMH) (2) · U.S. Army Medical Research and Development Command (2) · University of Rochester (2) · Centre Hospitalier Universitaire Dijon (1) · Centre Hospitalier Universitaire de Nice (1) · Centre Hospitalier de Saint-Denis (1) · Cephas Health Research Initiative Inc, Ibadan, Nigeria (1) · Claude Bernard University (1)
United States (15) · France (9) · Malawi (6) · Peru (5) · Tanzania (4) · Uganda (4) · Cameroon (1) · Canada (1) · Democratic Republic of the Congo (1) · Ecuador (1) · India (1) · Indonesia (1) · Mali (1) · Zambia (1)
Luft B (3) · Gretchen L Birbeck, M.D. (2) · Hector H. Garcia, MD, PhD (2) · Masahiro Fujita, M.D. (2) · Peter J Weina, MD, PhD (2) · Ajay Garg, MD DM (1) · Angela Loyse, MD (1) · Armando Gonzalez, DVM PhD (1) · Arunmozhimaran Elavarasi, MD DM (1) · B Luft (1) · BJ Luft (1) · Bernard J Ngowi, MD, PhD (1) · Besch CL (1) · Charles Ibingira, MMED (1) · Chirgwin K (1)
PMID 31672143, PMID 17958887, PMID 18495737, PMID 19630971, PMID 19852829, PMID 21332573, PMID 24999157, PMID 26984901, PMID 27355620, PMID 29749279, PMID 30745383, PMID 34020114, PMID 36961623, PMID 37802567, PMID 37983246, PMID 38279124, PMID 41748157, PMID 8615453, PMID 9364715, PMID 9840607
R01NS074409 (2), 2009 (1), R01NS054805 (1), R21NS069275 (1), SB1AI162452 (1), U01AI126610 (1)